Second Sight Medical Products, Inc. – NASDAQ:EYES

Add to watchlist

Market open

Closed in about 4 hours

+130.00%

month

+90.34%

quarter

+11.89%

year

Market Cap	210.04M
Enterprise value	N/A

P/E	-5.99
EV/Sales	N/A
EV/EBITDA	0.20
Price/Sales	N/A
Price/Book	0.86
PEG ratio	-0.09
EPS	-0.71

Revenue	N/A
EBITDA	-9.00M
Income	-9.07M
Revenue Q/Q	N/A
Revenue Y/Y	-74%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Second Sight Medical Products, Inc. (NASDAQ:EYES): Profit margin
Sep 2021	0	-2.50M
Dec 2021	260K	-1.28M	-493.46%
Mar 2022	0	-2.21M
Jun 2022	0	-3.07M

Second Sight Medical Products, Inc. (NASDAQ:EYES): Debt to assets
Sep 2021	73630000	4.02M	5.46%
Dec 2021	70879000	2.51M	3.55%
Mar 2022	68538000	2.38M	3.48%
Jun 2022	65649000	2.59M	3.95%

Second Sight Medical Products, Inc. (NASDAQ:EYES): Cash Flow
Sep 2021	-1.8M	0	0
Dec 2021	-2.42M	-14K	2K
Mar 2022	-1.97M	-8.01M	0
Jun 2022	-3.22M	0	0

Second Sight Medical Products alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Second Sight Medical Products
Employees

Second Sight Medical Products, Inc. (NASDAQ:EYES): Employee count
Aug 2023	15
Sep 2023	15
Oct 2023	15
Nov 2023	15
Dec 2023	15
Jan 2024	15
Feb 2024	15
Mar 2024	15
Apr 2024	15
May 2024	15
Jun 2024	15
Jul 2024	15

Second Sight Medical Products
Insider Trading

Second Sight Medical Products, Inc. (NASDAQ:EYES): Insider trades (number of shares)
Period	Buy	Sel
May 2019	0	3867
Jun 2019	0	23586
Aug 2019	0	3902
Feb 2020	0	1793

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	20 Feb 2020	MCGUIRE JONATHAN WILL director	Common Stock	1,793	$5.44	$9,754
Option	19 Feb 2020	MCGUIRE JONATHAN WILL director	Restricted Stock Units (RSUs)	5,532	N/A	N/A
Option	19 Feb 2020	RYAN WILLIAM PATRICK officer: Chief Operating Officer officer: Chief Operating Officer	Restricted Stock Units(RSUs)	3,594	N/A	N/A
Option	19 Feb 2020	BLAKE JOHN T officer: Chief Financial Officer officer: Chief Financial Officer	Restricted Stock Units(RSUs)	2,563	N/A	N/A
Sale	20 Aug 2019	MCGUIRE JONATHAN WILL director	Common Stock	3,902	$0.81	$3,153
Option	19 Aug 2019	MCGUIRE JONATHAN WILL director	Common Stock	11,875	N/A	N/A
Option	19 Aug 2019	MCGUIRE JONATHAN WILL director	Restricted Stock Units (RSUs)	11,875	N/A	N/A
Sale	4 Jun 2019	RANDOLPH EDWARD DAVID officer: Vice Pre..	Common Stock	23,586	$0.71	$16,652
Sale	21 May 2019	MCGUIRE JONATHAN WILL director	Common Stock	3,867	$0.85	$3,287
Option	20 May 2019	MCGUIRE JONATHAN WILL director	Common Stock	11,875	N/A	N/A

EYES insider trading transactions

Second Sight Medical Products
Patents

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Face detection tracking and recognition for a visual prosthesis Filling date: 29 Jan 2020 Issue date: 19 Jul 2022	29 Jan 2020	19 Jul 2022
Grant	Grant Utility: Depth filter for visual prostheses Filling date: 7 Dec 2017 Issue date: 12 Apr 2022	7 Dec 2017	12 Apr 2022
Grant	Grant Utility: Pattern detection and location in a processed image Filling date: 23 Jul 2019 Issue date: 1 Feb 2022	23 Jul 2019	1 Feb 2022
Grant	Grant Utility: Method and apparatus to provide safety checks for neural stimulation Filling date: 18 Jul 2019 Issue date: 18 Jan 2022	18 Jul 2019	18 Jan 2022
Grant	Grant Utility: Electrode array Filling date: 16 Sep 2019 Issue date: 11 Jan 2022	16 Sep 2019	11 Jan 2022
Grant	Grant Utility: Method and apparatus to provide safety checks for neural stimulation Filling date: 18 Jul 2019 Issue date: 16 Nov 2021	18 Jul 2019	16 Nov 2021
Grant	Grant Utility: Method and apparatus to provide safety checks for neural stimulation Filling date: 18 Jul 2019 Issue date: 16 Nov 2021	18 Jul 2019	16 Nov 2021
Grant	Grant Utility: Method and apparatus to provide safety checks for neural stimulation Filling date: 18 Jul 2019 Issue date: 28 Sep 2021	18 Jul 2019	28 Sep 2021
Grant	Grant Utility: Method and apparatus for fitting a visual prosthesis using electrically evoked responses Filling date: 17 May 2019 Issue date: 1 Jun 2021	17 May 2019	1 Jun 2021
Grant	Grant Utility: Method for providing hermetic electrical feedthrough Filling date: 24 Jun 2019 Issue date: 16 Mar 2021	24 Jun 2019	16 Mar 2021

EYES patents

Second Sight Medical Products
Earnings Call Transcripts

Quarter	Transcript
Q4 2019 19 Mar 2020	Q4 2019 Earnings Call Transcript
Q3 2019 15 Nov 2019	Q3 2019 Earnings Call Transcript
Q2 2019 7 Aug 2019	Q2 2019 Earnings Call Transcript
Q1 2019 16 May 2019	Q1 2019 Earnings Call Transcript

EYES earnings call transcripts

Second Sight Medical Products
Executives

Insider	Age	Compensation
Mr. Scott Dunbar (1957) Acting Chief Executive Officer	68	$255,300
Dr. Jessy Dana Dorn Ph.D. (1976) Vice President of Clinical & Scientific Affairs	49	$233,990
Mr. Edward David Randolph (1958) Vice President of Operations	67	$167,500
Mr. Edward Jonathon Sedo (1956) Acting Chief Accounting Officer & Principal Financial Officer	69	$151,080

Second Sight Medical Products
Latest News

Tuesday, 24 September 2024
00:01	FEAST YOUR EYES ON THE 2024 TRAVELERS' CHOICE AWARDS: BEST OF THE BEST RESTAURANTS REVEALED	prnewswire.com
Friday, 19 August 2022
07:10	Second Sight Medical Products (EYES) Stock: 1-For-3 Split Goes Into Effect	Pulse2
Tuesday, 8 February 2022
09:15	Trading Penny Stocks? Top Stock Market News For February 8th, 2022	PennyStocks
06:33	Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical	Benzinga

Frequently Asked Questions (FAQ)

When is Second Sight Medical Products's next earnings date?

Unfortunately, Second Sight Medical Products's (EYES) next earnings date is currently unknown.
Does Second Sight Medical Products pay dividends?

No, Second Sight Medical Products does not pay dividends.
How much money does Second Sight Medical Products make?

Second Sight Medical Products has a market capitalization of 210.04M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74% to -130K US dollars.
What is Second Sight Medical Products's stock symbol?

Second Sight Medical Products, Inc. is traded on the NASDAQ under the ticker symbol "EYES".
What is Second Sight Medical Products's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Second Sight Medical Products?

Shares of Second Sight Medical Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Second Sight Medical Products's key executives?
Second Sight Medical Products's management team includes the following people:
- Mr. Scott Dunbar Acting Chief Executive Officer(age: 68, pay: $255,300)
- Dr. Jessy Dana Dorn Ph.D. Vice President of Clinical & Scientific Affairs(age: 49, pay: $233,990)
- Mr. Edward David Randolph Vice President of Operations(age: 67, pay: $167,500)
- Mr. Edward Jonathon Sedo Acting Chief Accounting Officer & Principal Financial Officer(age: 69, pay: $151,080)
How many employees does Second Sight Medical Products have?

As Jul 2024, Second Sight Medical Products employs 15 workers.
When Second Sight Medical Products went public?

Second Sight Medical Products, Inc. is publicly traded company for more then 10 years since IPO on 19 Nov 2014.
What is Second Sight Medical Products's official website?

The official website for Second Sight Medical Products is secondsight.com.
Where are Second Sight Medical Products's headquarters?

Second Sight Medical Products is headquartered at 12744 San Fernando Rd Bldg 3, Sylmar, CALIFORNIA.
How can i contact Second Sight Medical Products?

Second Sight Medical Products's mailing address is 12744 San Fernando Rd Bldg 3, Sylmar, CALIFORNIA and company can be reached via phone at +1 818 833 5000.

Second Sight Medical Products, Inc.

secondsight.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Devices

Sector:

Healthcare

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

+1 818 833 5000

12744 San Fernando Rd Bldg 3
Sylmar, CALIFORNIA 91342

CIK: 0001266806
ISIN: US81362J2096
CUSIP: 81362J209